LC-MS/MS for immunosuppressant therapeutic drug monitoring

Bioanalysis

Volumn 2, Issue 6, 2010, Pages 1141-1153

  Sallustio, Benedetta C ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN D; EVEROLIMUS; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANALYTIC METHOD; DENSITY GRADIENT; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG STRUCTURE; ELECTROSPRAY; EXTRACELLULAR MATRIX; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR IMAGING; PHASE TRANSITION; PROCESS DEVELOPMENT; REVIEW; SENSITIVITY ANALYSIS; VALIDATION PROCESS; ARTIFACT; METHODOLOGY; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

ARTIFACTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 79151476298     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.58     Document Type: Review

References (78)

1. Wallemacq P, Armstrong VW, Brunet M et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther. Drug Monit. 31, 139-152 (2009).
2. Oellerich M, Armstrong VW. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. Ther. Drug Monit. 28, 720-725 (2006). (Pubitemid 44967650)
3. van Gelder T, Le Meur Y, Shaw LM et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther. Drug Monit. 28, 145-154 (2006). (Pubitemid 44314941)
4. Mabasa VH, Ensom MHH. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther. Drug Monit. 27, 666-676 (2005). (Pubitemid 41437646)
5. Shaw LM, Pawinski T, Korecka M, Nawrocki A. Monitoring of mycophenolic acid in clinical transplantation. Ther. Drug Monit. 24, 68-73 (2002). (Pubitemid 34106734)
6. Holt DW. Monitoring mycophenolic acid. Ann. Clin. Biochem. 39, 173-183 (2002). (Pubitemid 34494205)
7. Kahan BD, Keown P, Levy GA, Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin. Ther. 24, 330-350 (2002). (Pubitemid 34275858)
8. Soldin SJ, Steele BW, Witte DL, Wang E, Elin RJ. Lack of specificity of cyclosporine immunoassays. Arch. Pathol. Lab. Med. 127, 19-22 (2003).
9. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin. Chem. 45, 371-381 (1999). (Pubitemid 29114172)
10. Schutz E, Svinarov D, Shipkova M et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA and EMIT): a critical overview of performance characteristics and comparison with HPLC. Clin. Chem. 44, 2158-2214 (1998).
11. Shipkova M, Schutz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and EMIT. Clin. Chem. 46, 365-372 (2000). (Pubitemid 30152262)
12. Premaud A, Rousseau A, Le Meur Y, Lachatre G, Marquet P. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther. Drug Monit. 26, 609-619 (2004). (Pubitemid 39579141)
13. Baldelli S, Crippa A, Gabrieli R et al. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation. Clin. Biochem. 39, 1152-1159 (2006). (Pubitemid 44848323)
14. Bouzas L, Tutor JC. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay. Clin. Biochem. 40, 132-136 (2007). (Pubitemid 46014154)
15. Khoschsorur G, Fruehwirth F, Zeler S, Stettin M, Halwachs-Baumann G. Comparison of fluorescence polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation. Clin. Chim. Acta 380, 217-221 (2007). (Pubitemid 46498038)
16. Salm P, Taylor PJ, Pillans PI. The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle immunoassay in renal transplant recipients. Clin. Ther. 22 (Suppl. B), B71-B85 (2000). (Pubitemid 30306047)
17. Kuzuya T, Ogura Y, Motegi Y, Noriyama N, Nabeshima T. Interference of hematocrit in the Tacrolimus II microparticle enzyme immunoassay. Ther. Drug Monit. 24, 507-511 (2002). (Pubitemid 34857904)
18. Korecka M, Shaw LM. Review of the newest HPLC methods with mass spectrometry detection for the determination of immunosuppressive drugs in clinical practice. Ann. Transplant. 14, 61-72 (2009).
19. Yang Z, Wang S. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants. J. Immunol. Methods 336, 98-103 (2008).
20. Taylor PJ. Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther. Drug Monit. 26, 215-219 (2004). (Pubitemid 38501221)
21. Westley IS, Sallustio BC, Morris RG. Validation of a high performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma. Clin. Biochem. 38, 824-829 (2005). (Pubitemid 41097490)
22. Khoschsorur G, Erwa W. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol and acylglucuronide metabolites in plasma. J. Chromatogr. B 799, 355-360 (2004). (Pubitemid 37510240)
23. Shipkova M, Niedmann PD, Armstrong VW, Schutz E, Shaw LM, Oellerich M. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin. Chem. 44, 1481-1488 (1998). (Pubitemid 28309109)
24. Jones CE, Taylor PJ, Johnson AG. High-performance liquid chromatography determination of mycophenolic acid and its glucuronide metabolite in human plasma. J. Chromatogr. B 708, 229-234 (1998). (Pubitemid 28239909)
25. Atcheson BA, Taylor PJ, Mudge DW et al. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br. J. Clin. Pharmacol. 59, 271-280 (2004).
26. Weber LT, Shipkova M, Armstrong VW et al. The pharmacokinetic- pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J. Am. Soc. Nephrol. 13, 759-768 (2002). (Pubitemid 34183943)
27. Kaplan B, Gruber S, Nallamathou R, Katz SM, Shaw LM. Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. Transplantation 65, 1127-1129 (1998). (Pubitemid 28208433)
28. Nowak I, Shaw LM. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin. Chem. 41, 1011-1017 (1995).
29. Taylor PJ, Franklin ME, Graham KS, Pillans PI. A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimus. J. Chromatogr. B 848, 208-214 (2007). (Pubitemid 46454461)
30. Korecka M, Solari SG, Shaw LM. Sensitive, high throughput HPLC-MS/MS method with online sample clean-up for everolimus measurement. Ther. Drug Monit. 28, 484-490 (2006). (Pubitemid 44191893)
31. Salm P, Taylor PJ, Lynch SV, Warnholtz CR, Pillans PI. A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices. Clin. Biochem. 38, 667-673 (2005). (Pubitemid 40961638)
32. Salm P, Taylor PJ, Lynch SV, Pillans PI. Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography- electrospray tandem mass spectrometry. J. Chromatogr. B 772, 283-290 (2002). (Pubitemid 34499575)
33. Holt DW, Lee T, Jones K, Johnston A. Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. Clin. Chem. 46, 1179-1183 (2000). (Pubitemid 30643322)
34. Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (rapamycin) in blood by high-performance liquid-chromatography- electrospray tandem mass spectrometry. J. Chromatogr. B 718, 251-257 (1998). (Pubitemid 28499999)
35. Zhang Q, Simpson J, Aboleneen HI. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography-tandem mass spectrometry. Ther. Drug Monit. 19, 470-476 (1997). (Pubitemid 28074046)
36. Taylor PJ, Jones A, Balderson GA, Lynch SV, Norris RLG, Pond SM. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography- electrospray tandem mass spectrometry. Clin. Chem. 42, 279-285 (1996). (Pubitemid 26063884)
37. Taylor PJ, Salm P, Lynch SV, Pillans PI. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography- tandem mass spectrometry. Ther. Drug Monit. 22, 608-612 (2000).
38. Wang S, Magill JE, Vicente FB. A fast and simple high-performance liquid chromatography-mass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolimus. Arch. Pathol. Lab. Med. 129, 661-665 (2005). (Pubitemid 40616971)
39. Seger C, Tentschert K, Stoggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat. Protocols 4, 526-534 (2009).
40. Koster RA, Dijkers EC, Uges DR. Robust high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole-blood. Ther. Drug Monit. 31, 116-125 (2009).
41. Ceglarek U, Lembcke J, Fielder GM et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin. Chim. Acta 346, 181-190 (2004). (Pubitemid 38901049)
42. Koal T, Deters M, Casetta B, Kaever V. Simultaneous determination of four immunosuppressants by means of high speed and robust online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 805, 215-222 (2004). (Pubitemid 38596740)
43. Annesley TM, Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin. Chem. 50, 1845-1848 (2004). (Pubitemid 39298023)
44. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin. Chem. 48, 955-958 (2002). (Pubitemid 34587603)
45. Volosov A, Napoli KL, Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass spectrometry. Clin. Biochem. 34, 285-290 (2001). (Pubitemid 32607570)
46. O'Halloran S, Ilett KF. Evaluation of a deuterium labeled internal standard for the measurement of sirolimus by high-throughput HPLC electrospray ionization tandem mass spectrometry. Clin. Chem. 54, 1386-1389 (2008).
47. Hoogtanders K, van der Haijden J, Stolk LML, Neef C, Christians M, van Hooff J. Internal standard selection for the high-performance liquid chromatography tandem mass spectroscopy assay of everolimus in blood. Ther. Drug Monit. 29, 673-674 (2007). (Pubitemid 47494074)
48. Bogusz MJ, Enazi EA, Hassan H, Abdel-Jawaad J, Al Ruwaily J, Al Tufail M. Simultaneous LC-MS/MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J. Chromatogr. B 850, 474-480 (2007).
49. Ceglarek U, Casetta B, Lembcke J, Baumann S, Fielder GM, Thiery J. Inclusion of MPA and in a rapid multi-drug LC- tandem mass spectrometric method for simultaneous determination of immunosuppressants. Clin. Chim. Acta 373, 168-171 (2006). (Pubitemid 44292187)
50. Kuhn J, Prante C, Kleesiek K, Gotting C. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin. Biochem. 42, 83-90 (2009).
51. Brandhorst G, Streit F, Goetze S, Oellerich M, Armstrong VW. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Clin. Chem. 52, 1962-1964 (2006). (Pubitemid 44470706)
52. Annesley TM, Clayton L. Quantification of mycophenolic acid and glucuronide metabolites in human serum by HPLC-tandem mass spectrometry. Clin. Chem. 51, 872-877 (2005). (Pubitemid 40577924)
53. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin. Chem. 50, 152-159 (2004). (Pubitemid 38125712)
54. Atcheson B, Taylor PJ, Mudge DW, Johnson DW, Pillans PI, Tett SE. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid chromatography using mass spectrometric and ultraviolet absorbance detection. J. Chromatogr. B 799, 157-163 (2004). (Pubitemid 37500875)
55. Patel CG, Mendoza AE, Akhlaghi F et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J. Chromatogr. B 813, 287-294 (2004). (Pubitemid 39535457)
56. Atchison CR, West AB, Balakumaran A et al. Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats. Gastrornterology 119, 1537-1547 (2000). (Pubitemid 32198679)
57. Annesley TM. Ion suppression in mass spectrometry. Clin. Chem. 49, 1041-1044 (2003). (Pubitemid 36751088)
58. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38, 328-334 (2005). (Pubitemid 40342863)
59. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effects in quantitative bioanalytical methods based on HPLC-MS/ MS. Anal. Chem. 75, 3019-3030 (2003). (Pubitemid 36830428)
60. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11, 942-950 (2000). (Pubitemid 34546664)
61. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin. Chem. 53, 1827-1834 (2007). (Pubitemid 47509677)
62. Annesley TM. Application of commercial calibrators for the analysis of immunosuppressant drugs in whole blood. Clin. Chem. 51, 457-460 (2005). (Pubitemid 40175821)
63. Salm P, Taylor PJ, Rooney F. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood. Ther. Drug Monit. 30, 292-300 (2008).
64. Vogeser M, Zachoval R, Spohrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther. Drug Monit. 23, 722-724 (2001). (Pubitemid 33086505)
65. Taylor PJ, Brown SR, Cooper DP et al. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin. Chem. 51, 1890-1893 (2005). (Pubitemid 41368182)
66. Vogeser M, Spohrer U. Pitfall in the high-throughput quantitation of whole blood cyclosporin A using liquid chromatography- tandem mass spectrometry. Clin. Chem. Lab. Med. 43, 400-402 (2005). (Pubitemid 41460646)
67. Falck P, Guldseth H, Asbeg A, Midtvedt K, Reubsaet JLE. Determination of cyclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 852, 345-352 (2007). (Pubitemid 46830123)
68. Capron A, Musuamba F, Latinne D et al. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther. Drug Monit. 31, 178-186 (2009).
69. Benech H, Hascoet S, Furlan V, Pruvost A, Durrbach A. Development and validation of an LC-MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells. J. Chromatogr. B 853, 168-174 (2007). (Pubitemid 46900913)
70. Falck P, Asbeg A, Guldseth H et al. Declining intracellular T-lymphocyte concentration of cyclosporine A precedes acute rejection in kidney transplant recipients. Transplantation 85, 179-184 (2008). (Pubitemid 351156847)
71. Keevil BG, McCann SJ, Cooper DP, Morris MR. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann. Clin. Biochem. 39, 487-492 (2002).
72. Keevil BG, Fildes J, Baynes JW, Yonan N. Liquid chromatography-mass spectrometry measurement of tacrolimus in finger-prick samples compared with venous whole blood samples. Ann. Clin. Biochem. 46, 144-145 (2009).
73. Webb NJA, Roberts D, Preziosi R, Keevil BG. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Paediatr. Transplant. 9, 729-733 (2005). (Pubitemid 41680707)
74. Keevil BG, Tierney DP, Cooper DP, Morris MR, Machaal A, Yonan N. Simultaneous and rapid analysis of cyclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application in C2 monitoring. Ther. Drug Monit. 24, 757-767 (2002).
75. Wilhelm AJ, den Burger JCG, Vos RM, Chahbouni A, Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. J. Chromatogr. B 877, 1595-1598 (2009).
76. Cheung CY, van der Haijden J, Hoogtanders K et al. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transplant Int. 21, 140-145 (2008).
77. Hoogtanders K, van der Haijden J, Christiaans M, Edelbroek P, van Hooff J, Stolk LML. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J. Pharm. Biomed. Anal. 44, 658-664 (2007). (Pubitemid 47030763)
78. DiFrancesco R, Frerichs V, Donnelly J, Hagler C, Hochreiter J, Tornatore KM. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid-chromatography- tandem mass spectrometry. J. Chromatogr. B 859, 42-51 (2007). (Pubitemid 47626087)